Global Eperisone Market Size, Share and Trends Analysis Report, By Application (Neck Shoulder Wrist Syndrome, Shoulder Periarthritis, Musculoskeletal Pain, and Others), Forecast Period (2022-2028)

The global eperisone market is anticipated to grow at a CAGR of 4.3% during the forecast period (2022-2028). According to World Health Organization in February 2021, musculoskeletal conditions affect approximately 1.71 billion people across the globe. Low back pain is the most common musculoskeletal condition, affecting 568 million people globally. Musculoskeletal problems affect movement and dexterity severely, resulting in early retirement from work, poor well-being, and a reduced ability to participate in society. As a result of population expansion and aging, the number of people with musculoskeletal problems is steadily increasing. The number of people disabled by musculoskeletal illnesses has been increasing in recent decades, and this trend is projected to continue. With such a huge customer base available in the market and going to increase in future will propel the eperisone market growth.

Eperisone is a muscle relaxant that acts on the central nervous system. It can diminish the sensitivity of the muscular spindle by blocking the spinal cord reflex, reducing the spontaneous impulse of my motor neurons, and thereby relieving the tension of the skeletal muscle by acting on the spinal cord and vascular smooth muscle. And by expanding blood vessels and boosting blood circulation, muscle tension hyperactivity, a circulation disorder, muscular pain muscle tension hyperactivity, and other skeletal muscle tension vicious circles can be broken in many ways. With the increase in outdoor sports and athletics, there are a lot of neck-shoulder wrist injuries that take place in the field, which is another factor that drives the eperisone market in the anticipated period.

Some major players in the market include Bracco S.p.A., DAEWON, Eisai Co., Ltd., Hanmi Pharmaceutical co., ltd., and Hunan Yada Pharmaceutical Co., Ltd., Zambon S.p.A, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Company’s Product Portfolio

• Eisai Co., Ltd. offers EprisanSR Capsule as a muscle relaxer. It relieves the pain and suffering of acute, unpleasant musculoskeletal problems such as rigidity, tension, stiffness, and muscular spasms.
• For instance, Abbott offers Rapisone- SR Capsule as a muscle relaxer. It relieves the pain and suffering of acute, unpleasant musculoskeletal problems such as rigidity, tension, stiffness, and muscular spasms.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape– Bracco S.p.A., DAEWON, Eisai Co., Ltd., Hanmi Pharmaceutical co., ltd., Hunan Yada pharmaceutical Co., Ltd., Zambon S.p.A, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Eperisone Market Report by Segment

By Application

• Neck Shoulder Wrist Syndrome
• Shoulder Periarthritis
• Musculoskeletal Pain
• Other (Lumbar Pains,  Spastic Paralysis)

Global Eperisone Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa